The following are appropriate:

Clinical follow-up during and after infancy to confirm that CNS disease is not progressive (in contrast to free sialic acid storage disorders) and to document the gradual remission of signs and/or symptoms present in infancy

Follow-up evaluations three to four times in infancy, twice in the second year of life, and once every subsequent year
